| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |